HROW:NASDAQ
Harrow Inc
30,35 US$
arrow_downward
-0,75%(-0,23) 1K
31,69 US$
arrow_upward
+4,42% (+1,34)bedtimeYopilgandan keyin
Savdolar yopilgan: 6-okt, 16:00:01 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoHROW tikeri uchun statistika yaratilmoqda...
Ochish
30,86 US$
Yuqori
30,90 US$
Past
29,84 US$
Bozor kapitali
1,13 mlrd
Oʻrtacha hajm
542,22 ming
Hajmi
422,00 ming
52 haftalik eng yuqori
54,85 US$
52 haftalik eng past
28,54 US$
Aksiya boʻyicha daromad
-1,00 US$
Beta
0,19
Muomaladagi aksiyalar
37,49 mln
Xodimlar soni
373
Ochish
30,86 US$
Yuqori
30,90 US$
Past
29,84 US$
Bozor kapitali
1,13 mlrd
Oʻrtacha hajm
542,22 ming
Hajmi
422,00 ming
52 haftalik eng yuqori
54,85 US$
52 haftalik eng past
28,54 US$
Aksiya boʻyicha daromad
-1,00 US$
Beta
0,19
Muomaladagi aksiyalar
37,49 mln
Xodimlar soni
373
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
The Business Journals
·
1 kun oldin
Harrow invests $30 million in new pharmaceutical as it builds portfolio
AD HOC NEWS
·
1 kun oldin
Harrow Health stock gets TYRVAYA after USD 30 million deal
TipRanks
·
1 kun oldin
Harrow Closes TYRVAYA Acquisition, Expanding Dry Eye Portfolio
Profil
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company. In 2017, Harrow started and funded Eton Pharmaceuticals with a $20 million Series A financing, and Eton is now a publicly traded company. In 2017, Harrow started Surface Pharmaceuticals, hiring Dr. Kamran Hosseini to be its chief executive officer. Surface was funded with a $20 million Series A financing with Flying L Partners leading the round. In 2018, Harrow started Melt Pharmaceuticals and announced an $11 million Series A financing.
In 2019, Harrow hired founder and former CEO of Doxy.me, Drew Livingston, as its chief innovation officer. Livingston is the senior executive of Harrow's Visionology.com telemedicine subsidiary. Wikipedia
Harrow Inc haqida
CEOMark L. Baum Esq.
Xodimlar soni373
Asos solingan2012
Bosh ofislarNashville, Tennessi, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytharrow.com